NHI NATIONAL HEALTH INVESTORS INC
Real Estate Investment Trusts · NYSE · SEC CIK 877860 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY28.2%
TTM net income YoY373.6%
TTM EPS YoY350.3%
Revenue 3-yr CAGR13.6%
Net income 3-yr CAGR87.7%
Margins
Gross margin—
Operating margin—
Net margin153.0%
FCF margin—
EBITDA margin—
Returns
ROE39.1%
ROA23.5%
ROIC (approx.)—
Asset turnover0.15x
Leverage & solvency
Liabilities / assets35.0%
Debt / equity0.00x
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.34x
Accruals ratio15.6%
Payout ratio25.5%
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $375.63M | $335.18M | $319.83M | $278.19M | $298.71M |
| SG&A expense | $26.87M | $20.74M | $19.31M | $22.77M | $18.43M |
| Interest expense | $57.37M | $59.90M | $58.16M | $44.92M | $50.81M |
| Net income | $142.18M | $137.99M | $135.65M | $66.40M | $111.80M |
| EPS (basic) | 3.03 | 3.14 | 3.13 | 1.48 | 2.45 |
| EPS (diluted) | 3.02 | 3.13 | 3.13 | 1.48 | 2.44 |
| Dividends declared per share | 3.64 | 3.60 | 3.60 | 3.60 | 3.80 |
| Weighted avg. shares (diluted) | 47.05M | 44.10M | 43.39M | 44.79M | 45.73M |
| Banking | |||||
| Net interest income | — | — | $268.74M | $240.21M | — |
| Loans, net | $203.30M | $268.93M | $245.27M | $233.14M | $299.95M |
| Balance sheet | |||||
| Cash & equivalents | $19.62M | $24.29M | $22.35M | $21.52M | $39.48M |
| Receivables | — | — | — | $3.62M | $3.21M |
| PP&E, net | $2.47B | $2.21B | $2.11B | $2.12B | $2.32B |
| Total assets | $2.80B | $2.61B | $2.49B | $2.51B | $2.84B |
| Total liabilities | $1.26B | $1.23B | $1.21B | $1.22B | $1.32B |
| Shareholders' equity | $1.52B | $1.37B | $1.25B | $1.27B | $1.51B |
| Shares outstanding | 48.30M | 45.69M | 43.41M | 43.39M | 45.85M |
| Cash flow statement | |||||
| Operating cash flow | $236.56M | $207.77M | $184.45M | $185.34M | $210.86M |
| Capital expenditure | $294.03M | $157.93M | $49.56M | $10.99M | $50.35M |
| Free cash flow | -$57.47M | $49.84M | $134.89M | $174.35M | $160.51M |
| Investing cash flow | -$269.15M | -$192.31M | -$11.63M | $197.94M | $185.28M |
| Financing cash flow | $25.71M | -$13.57M | -$169.72M | -$401.25M | -$402.99M |
| Depreciation & amortization | $80.94M | $71.44M | $69.97M | $70.88M | $80.80M |
| Stock-based compensation | $5.58M | $4.18M | $4.61M | $8.61M | $8.41M |
| Dividends paid | $169.70M | $156.51M | $156.24M | $161.77M | $182.90M |
| Share buybacks | — | $0 | $0 | $151.95M | $0 |
Free plan shows the latest 5 periods; Pro shows all 18 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.